BHVN Biohaven Pharmaceutical Holding Co

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.

$16.74  +0.21 (1.27%)
As of 12/02/2022 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  British Virgin Islands
IPO date:  05/04/2017
Outstanding shares:  68,160,979
Average volume:  898,495
Market cap:   $1,126,700,983
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BPLZ7S5
Valuation   (See tab for details)
PE ratio:   -1.44
PB ratio:   8.01
PS ratio:   1.53
Return on equity:   150.99%
Net income %:   -94.64%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy